Changes in Respiratory Syncytial Virus‐Associated Hospitalisations Epidemiology After Nirsevimab Introduction in Lyon, France
High Nirsevimab coverage and effectiveness were estimated in a real-world setting. A change in the age distribution of RSV-associated LRTI hospitalisations in 2023-2024 was noted compared with historical seasons.
Authors
- Étienne Javouhey (ORCID: https://orcid.org/0000-0002-6480-0758)
- Marta Coelho Nunes (ORCID: https://orcid.org/0000-0003-3788-878X)
- Jean‐Sébastien Casalegno (ORCID: https://orcid.org/0000-0003-3271-9856)
- Côme Horvat (ORCID: https://orcid.org/0009-0008-1954-1639)
- Yves Gillet
- Marine Butin (ORCID: https://orcid.org/0000-0001-9453-4641)
- Cécile Chauvel (ORCID: https://orcid.org/0009-0005-2563-5816)
- Dominique Ploin (ORCID: https://orcid.org/0000-0002-9668-7606)
- Claire Nour Abou Chakra (ORCID: https://orcid.org/0000-0002-3345-0580)
- Juliette Hassenboehler
- Corinne Ragouilliaux
- Franck Plaisant
Institutions
- Université Claude Bernard Lyon 1 (FR)
- École Normale Supérieure de Lyon (FR)
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- University of the Witwatersrand (ZA)
- Hôpital Femme Mère Enfant (FR)
- Hôpital de la Croix-Rousse (FR)
- Hospices Civils de Lyon (FR)
- Hôpital Lyon Sud (FR)
- Virologie et Pathologies Humaines (FR)
- Centre International de Recherche en Infectiologie (FR)
Publication Details
- Journal
- Influenza and Other Respiratory Viruses
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1111/irv.70054
- Citations
- 7
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 2.71
Funders
- Sanofi
- Hospices Civils de Lyon
- Université Claude Bernard Lyon 1